Australia's most trusted
source of pharma news
Posted 6 August 2025 AM
Merck has thrown its support behind the production of a manual containing new expert guidance to harmonise the dynamic tests used in the diagnosis and treatment of endocrine disorders in children across Australia and New Zealand.
The new protocols, published this month in a manual titled Australian and New Zealand Harmonised Paediatric Endocrine Dynamic Testing Manual, were launched at the Australia and New Zealand Society for Paediatric Endocrinology and Diabetes (ANZSPED) Annual Scientific Meeting taking place in Cairns this week.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.